Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting ...

San Francisco-based Trace Neuroscience has launched with $101 million in series A funding to develop ALS therapies focused on ...

Ten years after her sexual assault, she discovered that the evidence in her rape kit hadn’t been tested — and neither had ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

The FDA initially halted the trials on 16 October after a patient in the Phase II trial (NCT05519839) of the CIC vaccine ...

Scientists are working on a way to restore the production of a protein that is essential for communication in the brain and ...

The condition is a rapidly progressive neurodegenerative disorder leading to wasting, paralysis and eventual death from ...

Friends and family gathered on Friday night to bid farewell to community leader and nature promoter Omar Gallardo with an ...

Amyotrophic lateral sclerosis (ALS) is the most common form of MND and there is currently no cure for the condition which ...